Ilaria Defilippi

Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Emanuela Messa, Sonia Carturan, Chiara Maffè et al. · Haematologica · 2010 · 131 citations · Full text

Medicine, Hematology, Pharmacology +17

The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance

Daniela Cilloni, F. Messa, Francesca Arruga et al. · Leukemia · 2005 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

Daniela Cilloni, F. Messa, Francesca Arruga et al. · Haematologica · 2008 · 91 citations · Full text

Medicine, Hematology, Oncology +16

Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-α and Tfr2-β isoforms in different tissues

Antonella Roetto, Ferdinando Di Cunto, Rosa Maria Pellegrino et al. · Blood · 2010 · 71 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +3

NF‐kB inhibition as a strategy to enhance etoposide‐induced apoptosis in K562 cell line

Alessandro Morotti, Daniela Cilloni, Marisa Pautasso et al. · American Journal of Hematology · 2006 · 52 citations · Full text

Life Sciences, Oncology, Pharmacology +17